ArticleNeuromolecular medicine2023

ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma.

Livia Fratini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.